SCYNEXIS, Inc. (SCYX): Price and Financial Metrics

SCYX POWR Grades

• Value is the dimension where SCYX ranks best; there it ranks ahead of 64.23% of US stocks.
• The strongest trend for SCYX is in Momentum, which has been heading down over the past 47 weeks.
• SCYX's current lowest rank is in the Momentum metric (where it is better than 4.63% of US stocks).

SCYX Stock Summary

• SCYX has a higher market value than only 15.53% of US stocks; more precisely, its current market capitalization is $137,217,842.
• With a year-over-year growth in debt of 102.07%, Scynexis Inc's debt growth rate surpasses 91.75% of about US stocks.
• Scynexis Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -87.33%, greater than the shareholder yield of just 2.4% of stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Scynexis Inc are MOSY, HSTO, APVO, KLIC, and ICCC.
• Visit SCYX's SEC page to see the company's official filings. To visit the company's web site, go to www.scynexis.com.

SCYX Valuation Summary

• In comparison to the median Healthcare stock, SCYX's price/sales ratio is 11.01% higher, now standing at 12.6.
• SCYX's EV/EBIT ratio has moved up 1.3 over the prior 89 months.
• SCYX's EV/EBIT ratio has moved up 1.3 over the prior 89 months.

Below are key valuation metrics over time for SCYX.

SCYX Growth Metrics

• Its 2 year net cashflow from operations growth rate is now at -75.65%.
• The 4 year cash and equivalents growth rate now stands at -46.01%.
• Its 4 year net cashflow from operations growth rate is now at -57.73%.

Over the past 70 months, SCYX's revenue has gone up $3,328,000.

The table below shows SCYX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	12.05	-38.895	-44.82
2021-03-31	12.05	-36.056	-52.859
2020-12-31	0	-49.354	-55.185
2020-09-30	0	-46.24	-26.932
2020-06-30	0	-46.773	-35.782
2020-03-31	0.057	-45.675	-37.804

SCYX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• SCYX has a Quality Grade of C, ranking ahead of 30.64% of graded US stocks.
• SCYX's asset turnover comes in at 0.134 -- ranking 233rd of 677 Pharmaceutical Products stocks.
• ACER, MNOV, and OVID are the stocks whose asset turnover ratios are most correlated with SCYX.

The table below shows SCYX's key quality metrics over time.